Insulet Corporation (PODD) 42.19 $PODD Will Insulet

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 3:26 PM

Insulet Corporation (PODD) 42.19 $PODD

Will Insulet (PODD) Crush Estimates at Its Next Earnings Report?
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 7:44AM CDT
Insulet (PODD) has seen a nice streak of beating earnings estimates and looks set to crush analyst expectations in its next earnings report
PODD: 42.19 (-0.14)

Uptrend Call Working As Insulet Stock Rises 35.8% (PODD)
Comtex SmarTrend(R) - Tue Aug 30, 1:21PM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQ

ODD) on July 8th, 2016 at $31.92. In approximately 2 months, Insulet has returned 35.81% as of today's recent price of $43.35.
PODD: 42.19 (-0.14)

Moving Average Crossover Alert: Insulet (PODD)
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 9:47AM CDT
Insulet Corporation (PODD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
PODD: 42.19 (-0.14)

38.3% Return Seen to Date on SmarTrend Insulet Call (PODD)
Comtex SmarTrend(R) - Mon Aug 15, 1:10PM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQ

ODD) on July 8th, 2016 at $31.92. In approximately 1 month, Insulet has returned 38.28% as of today's recent price of $44.14.
PODD: 42.19 (-0.14)

Can The Uptrend Continue for Insulet (PODD)?
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 8:15AM CDT
Investors certainly have to be happy with Insulet Corporation (PODD) and its short term performance
PODD: 42.19 (-0.14)

Shares of PODD Up 32.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 05, 1:17PM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQ

ODD) on July 8th, 2016 at $31.92. In approximately 4 weeks, Insulet has returned 32.82% as of today's recent price of $42.40.
PODD: 42.19 (-0.14)

After Yesterday's Rally of 21.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Aug 04, 12:56PM CDT
Insulet (NASDAQ

ODD) traded in a range yesterday that spanned from a low of $39.25 to a high of $43.48. Yesterday, the shares gained 21.6%, which took the trading range above the 3-day high of $36.31 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PODD: 42.19 (-0.14)

Insulet Reports Second Quarter 2016 Financial Results
BusinessWire - Wed Aug 03, 3:01PM CDT
--Company Raises Mid-Point of Full Year 2016 Revenue Guidance by $10 Million
PODD: 42.19 (-0.14)

Insulet Corporation to Present at Upcoming Investor Conferences
BusinessWire - Mon Aug 01, 3:05PM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City, New York:
PODD: 42.19 (-0.14)

Health insurer's limit on insulin pumps worries patients
By TOM MURPHY - AP - Fri Jun 24, 10:18AM CDT
Stephanie Rodenberg-Lewis wasn't happy with her insulin pump and finally switched two years ago to another brand. Now her health insurer is pushing her to go back.
PODD: 42.19 (-0.14), UNH: 135.56 (-0.49), AET: 115.99 (-1.13)

What Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
PR Newswire - Fri Jun 24, 6:49AM CDT
Since the financial crisis, the Healthcare sector has proven to be defensive against market downturns, continuing to present opportunities for growth. Today's featured companies on Stock-Callers.com belong in this arena: Antares Pharma Inc. (NASDAQ: ATRS), Globus Medical Inc. (NYSE: GMED), NuVasive Inc. (NASDAQ: NUVA), and Insulet Corp. (NASDAQ: PODD). Learn more about these stocks and receive your complimentary trade alerts at:
PODD: 42.19 (-0.14), GMED: 23.36 (+0.13), NUVA: 65.81 (+0.34), ATRS: 1.22 (unch)

First Week of PODD August 19th Options Trading
DividendChannel.com - Tue Jun 21, 9:49AM CDT
Investors in Insulet Corp saw new options begin trading this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PODD options chain for the new August 19th contracts and identified one...
PODD: 42.19 (-0.14)

Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet's Clinical Team
BusinessWire - Fri Jun 10, 5:00AM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System, today announced that almost 100 members of Insulet's North American clinical team have completed a customized certification program designed and led by the Joslin Diabetes Center for Insulet. The Advanced Diabetes Educator in Pump Therapy (ADEPT(TM)) certification provides Insulet's clinical team with customized, advanced training to deliver enhanced support for individuals who are managing their diabetes using continuous subcutaneous insulin infusion therapy. The Company's partnership with Joslin will enable Insulet's clinical team to provide unparalleled training and support for healthcare practitioners and their Omnipod patients.
PODD: 42.19 (-0.14)

Insulet to Present Omnipod(R) Clinical Studies on Type 1 and Type 2 Diabetes During the American Diabetes Association's 76th Scientific Sessions
BusinessWire - Wed Jun 08, 5:38PM CDT
--Dr. Frank Doyle to Share Exciting New Data on the Insulet-Licensed Artificial Pancreas Algorithm
PODD: 42.19 (-0.14)

Insulet Rises 2.31% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 23, 4:28PM CDT
Insulet (NASDAQ

ODD) traded in a range yesterday that spanned from a low of $28.33 to a high of $29.42. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $28.86 on volume of 332,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PODD: 42.19 (-0.14)

Insulet Launches New Omnipod(R) Podder(TM) Community Platform
BusinessWire - Mon May 23, 5:00AM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced the launch of a new online user community platform. This new platform will increase patient engagement and awareness of Omnipod by empowering Omnipod customers to share their experiences and insights and provide support to the large and growing Podder(TM) community. The launch of the Podders community platform coincides with Insulet's exciting new patient mobile app and branding, as well as the Company's debut on social media via Facebook (myomnipod) and Twitter (@myomnipod).
PODD: 42.19 (-0.14)

Why Insulet Corporation and Tandem Diabetes Care Both Tanked Today
Brian Feroldi, The Motley Fool - Motley Fool - Tue May 03, 3:50PM CDT
PHOTO CREDIT: INSULET. What: Shares of Insulet Corporation and Tandem Diabetes Care , both medical-device companies primarily focused on creating products that help treat diabetes, plunged by double digits today after Tandem released some...
PODD: 42.19 (-0.14), TNDM: 7.00 (-0.13)

Insulet Pumps Out 69% Revenue Growth in Q1, Reaffirms 2016 Guidance
Beth McKenna, The Motley Fool - Motley Fool - Tue May 03, 2:04PM CDT
Insulet reported its first-quarter 2016 earnings after the market closed on Thursday. The drug delivery company, which is a leader in tubeless insulin pump technology with its OmniPod System, posted revenue growth that exceeded its...
PODD: 42.19 (-0.14), AMGN: 169.35 (-0.71)

Insulet Reaffirms Second Quarter and Full Year 2016 Guidance
PR Newswire - Tue May 03, 1:35PM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today reaffirmed its second quarter and full year 2016 guidance. A recent preferred provider communication by UnitedHealthcare regarding in-network DME insulin pumps is not expected to have a material impact on OmniPod System coverage nor on Insulet's financial results.
PODD: 42.19 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Lawsuit Hits Desert Resort Management

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Colson Group Expands with Algood Acquisition

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...

Elevest's Fund 70: High Hopes in Dallas Tower Deal

Aiming High in the Heart of Dallas Rolling the dice in downtown Dallas isn't for the faint-hearted, but Elevest Capital is strutting in with swagger. Their 70th fund acquisition—a 229-unit high-rise—is rocking the highest going-in cap rate the firm has ever snagged at 6.4%. Built in 2007 and lounging at a comfy 93% occupancy with zero concessions, this property sure...

Perkins Rolls Out Mahjong to Revive Family Bonds

Perkins Ditches the Phones, Sparks True Connection No doubt about it, folks—Perkins Restaurant & Bakery has cooked up something special to bring families back to the table. Not just for pancakes or pies this time, but for a little classic game action with their limited-edition Mahjong set. Love it or leave it, this is Perkins tapping into the magic of togetherness...

Newsom's Veto Sparks Controversy Over Wildfire Insurance

A Flames of Controversy Light Up California's Insurance Arena Some days, you look at the headlines and just think, "What the heck is going on here?" When Governor Gavin Newsom struck down two critical bills designed to help wildfire survivors, it wasn't just bureaucratic arm-wrestling. It landed like a gut punch to a state already licking its wounds from raging wildfires....

J.P. Morgan, Thunes Partner for Global Payment Integration

You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...

LifeLabs' AI Program: A Manager's New Toolbox

Management In the Age of AI: New Frontiers Gone are the days when a simple software update meant staying competitive. We're in a new era, folks—one where AI isn't just a handy tool—it's reshaping entire industries. But here's the kicker: all the fancy tech in the world won't do squat without savvy managers who know how to drive adoption. Yup, that's the naked truth,...

NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

RiskScout Rides High on Funding, Tackles Financial Crime

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...